|
MAGLUMI X10 CLIA Analyzer – Ultra-High Throughput Chemiluminescence Immunoassay System
High-volume diagnostics is a logistics problem as much as a science problem. The MAGLUMI X10 reflects how Chinese manufacturers are engineering for the bottleneck.
A central lab processing thousands of immunoassay panels daily operates on a simple constraint: time per result. Snibe’s MAGLUMI X10, a fully automated chemiluminescence analyzer, is built to collapse that cycle. With a single module rated at 1,000 tests per hour and a four-module stack reaching 4,000, the machine is less an instrument than a miniaturized production line.
Its footprint—just 2.4 square meters—means throughput density is high. Capacity for 300 samples and 50 onboard reagent positions, managed via RFID tracking, allows continuous operation without frequent reloads. The 10-microliter pipetting precision and integrated wash systems reduce carry-over risk, a non-negotiable in high-speed batch testing.
The X10 is designed for medium-to-large hospitals and diagnostic centers already moving toward total laboratory automation (TLA). Its ability to interface with track-based LAS systems places it as a component within a broader workflow, not a standalone box. That matters in procurement: labs prioritize vendors whose hardware fits existing automation architecture.
Snibe, the Shenzhen-based manufacturer, competes in a segment historically dominated by Roche, Abbott, and Siemens. The X10’s performance metrics—particularly module scalability and reagent intelligence—signal that Chinese CLIA platforms are now targeting the same Tier 1 hospital tenders and large-scale reference labs. The technical gap is narrowing.
For the operator, the machine removes friction from the middle of the lab workflow: reagent swaps, manual checks, and downtime between batches. For the supply chain, it represents a high-frequency purchasing node with predictable consumable demand. Reagent contracts, not the hardware, drive the economic logic.
Why it matters:
The X10 shows that Chinese diagnostic equipment can now deliver the throughput and integration required by large-scale clinical operations. For buyers weighing cost vs. legacy lock-in, the choice is becoming less obvious than it was five years ago.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.